Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytosis, Langerhans-Cell × olaparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 15 Fallopian Tube Neoplasms 11 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Neoplasms 4 Endometrial Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Glioblastoma 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Osteosarcoma 1 Inflammatory Breast Neoplasms 1 High Grade Serous Carcinoma 1

Interventions

X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 trametinib 1 etoposide phosphate 1 erdafitinib 1 ensartinib 1 dabrafenib 1 Sirolimus 1 Genetic Testing 1 Etoposide 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡